Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

Item

http://www.wikidata.org/entity/Q34085163

Q34085163

about

Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

Item

http://www.wikidata.org/entity/Q34085163

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@ast

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@en

Tamoxifen plus tegafur-uracil

@nl

type

Item

label

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@ast

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@en

Tamoxifen plus tegafur-uracil

@nl

prefLabel

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@ast

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@en

Tamoxifen plus tegafur-uracil

@nl

P1476

Tamoxifen plus tegafur-uracil ...... ical Oncology Group Study 9404

@en

P2093

Haruhiko Fukuda

http://www.w3.org/2001/XMLSchema#string

Hiroji Iwata

http://www.w3.org/2001/XMLSchema#string

Jiro Ando

http://www.w3.org/2001/XMLSchema#string

Kenichi Nakamura

http://www.w3.org/2001/XMLSchema#string

Kenjiro Aogi

http://www.w3.org/2001/XMLSchema#string

Seiki Takashima

http://www.w3.org/2001/XMLSchema#string

Tadahiko Shien

http://www.w3.org/2001/XMLSchema#string

Takashi Fukutomi

http://www.w3.org/2001/XMLSchema#string

Takayuki Kinoshita

http://www.w3.org/2001/XMLSchema#string

Taro Shibata

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab containing regimens for early breast cancer

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group.

P2888

s00280-014-2545-2

P304

603-609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-014-2545-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kenichi Inoue

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264202462

http://www.w3.org/2001/XMLSchema#string

P6179

1045145567

http://www.w3.org/2001/XMLSchema#string

P698

25055938

http://www.w3.org/2001/XMLSchema#string

P932

4143604

http://www.w3.org/2001/XMLSchema#string

Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

about

Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932